| Gene expression predictors of breast cancer outcomes E Huang, SH Cheng, H Dressman, J Pittman, MH Tsou, CF Horng, A Bild, ... The Lancet 361 (9369), 1590-1596, 2003 | 824 | 2003 |
| Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer SE Bojesen, KA Pooley, SE Johnatty, J Beesley, K Michailidou, JP Tyrer, ... Nature genetics 45 (4), 371-384, 2013 | 648 | 2013 |
| BRCAPRO Validation, Sensitivity of Genetic Testing of BRCA1/BRCA2, and Prevalence of Other Breast Cancer Susceptibility Genes DA Berry, ES Iversen Jr, DF Gudbjartsson, EH Hiller, JE Garber, ... Journal of Clinical Oncology 20 (11), 2701-2712, 2002 | 574 | 2002 |
| A systematic genetic assessment of 1,433 sequence variants of unknown clinical significance in the BRCA1 and BRCA2 breast cancer–predisposition genes DF Easton, AM Deffenbaugh, D Pruss, C Frye, RJ Wenstrup, ... The American Journal of Human Genetics 81 (5), 873-883, 2007 | 520 | 2007 |
| GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer PDP Pharoah, YY Tsai, SJ Ramus, CM Phelan, EL Goode, K Lawrenson, ... Nature genetics 45 (4), 362-370, 2013 | 419 | 2013 |
| Characterization of BRCA1 and BRCA2 mutations in a large United States sample S Chen, ES Iversen, T Friebel, D Finkelstein, BL Weber, A Eisen, ... Journal of clinical oncology: official journal of the American Society of …, 2006 | 419 | 2006 |
| Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer CM Phelan, KB Kuchenbaecker, JP Tyrer, SP Kar, K Lawrenson, ... Nature genetics 49 (5), 680-691, 2017 | 401 | 2017 |
| A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24 EL Goode, G Chenevix-Trench, H Song, SJ Ramus, M Notaridou, ... Nature genetics 42 (10), 874-879, 2010 | 391 | 2010 |
| Global control of cell-cycle transcription by coupled CDK and network oscillators DA Orlando, CY Lin, A Bernard, JY Wang, JES Socolar, ES Iversen, ... Nature 453 (7197), 944-947, 2008 | 379 | 2008 |
| Gene expression profiling and genetic markers in glioblastoma survival JN Rich, C Hans, B Jones, ES Iversen, RE McLendon, BKA Rasheed, ... Cancer research 65 (10), 4051-4058, 2005 | 376 | 2005 |
| A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22. 2 H Song, SJ Ramus, J Tyrer, KL Bolton, A Gentry-Maharaj, E Wozniak, ... Nature genetics 41 (9), 996-1000, 2009 | 341 | 2009 |
| Patterns of gene expression that characterize long-term survival in advanced stage serous ovarian cancers A Berchuck, ES Iversen, JM Lancaster, J Pittman, J Luo, P Lee, S Murphy, ... Clinical cancer research 11 (10), 3686-3696, 2005 | 319 | 2005 |
| Identification of six new susceptibility loci for invasive epithelial ovarian cancer KB Kuchenbaecker, SJ Ramus, J Tyrer, A Lee, HC Shen, J Beesley, ... Nature genetics 47 (2), 164-171, 2015 | 309 | 2015 |
| Common variants at 19p13 are associated with susceptibility to ovarian cancer KL Bolton, J Tyrer, H Song, SJ Ramus, M Notaridou, C Jones, T Sher, ... Nature genetics 42 (10), 880-884, 2010 | 293 | 2010 |
| Integrated modeling of clinical and gene expression information for personalized prediction of disease outcomes J Pittman, E Huang, H Dressman, CF Horng, SH Cheng, MH Tsou, ... Proceedings of the National Academy of Sciences 101 (22), 8431-8436, 2004 | 274 | 2004 |
| Effect of hysterectomy with ovarian preservation on ovarian function PG Moorman, ER Myers, JM Schildkraut, ES Iversen, F Wang, N Warren Obstetrics & Gynecology 118 (6), 1271-1279, 2011 | 270 | 2011 |
| Methylation variation at IGF2 differentially methylated regions and maternal folic acid use before and during pregnancy C Hoyo, AP Murtha, JM Schildkraut, RL Jirtle, W Demark-Wahnefried, ... Epigenetics 6 (7), 928-936, 2011 | 267 | 2011 |
| Gender-specific methylation differences in relation to prenatal exposure to cigarette smoke SK Murphy, A Adigun, Z Huang, F Overcash, F Wang, RL Jirtle, ... Gene 494 (1), 36-43, 2012 | 254 | 2012 |
| PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS MC Southey, DE Goldgar, R Winqvist, K Pylkäs, F Couch, M Tischkowitz, ... Journal of medical genetics 53 (12), 800-811, 2016 | 240 | 2016 |
| Genetic evidence and integration of various data sources for classifying uncertain variants into a single model DE Goldgar, DF Easton, GB Byrnes, AB Spurdle, ES Iversen, ... Human mutation 29 (11), 1265-1272, 2008 | 226 | 2008 |
